143 related articles for article (PubMed ID: 30880770)
1. Preoperative assessment of malignant potential of gastrointestinal stromal tumor by dual-time-point 18F-fluorodeoxyglucose positron emission tomography imaging: Usefulness of standardized uptake value and retention index.
Kwon Y; Park E; Pahk K; Kim S; Kim MJ; Graf D; Park S
J Cancer Res Ther; 2019; 15(1):142-147. PubMed ID: 30880770
[TBL] [Abstract][Full Text] [Related]
2. The predictive value of preoperative
Miyake KK; Nakamoto Y; Mikami Y; Tanaka S; Higashi T; Tadamura E; Saga T; Minami S; Togashi K
Eur Radiol; 2016 Dec; 26(12):4664-4674. PubMed ID: 26852217
[TBL] [Abstract][Full Text] [Related]
3. Dual-phase 18F-fluoro-2-deoxy-D-glucose positron emission tomography as a prognostic parameter in patients with pancreatic cancer.
Lyshchik A; Higashi T; Nakamoto Y; Fujimoto K; Doi R; Imamura M; Saga T
Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):389-97. PubMed ID: 15372209
[TBL] [Abstract][Full Text] [Related]
4. The Clinical Role of Dual-Time-Point (18)F-FDG PET/CT in Differential Diagnosis of the Thyroid Incidentaloma.
Lee S; Park T; Park S; Pahk K; Rhee S; Cho J; Jeong E; Kim S; Choe JG
Nucl Med Mol Imaging; 2014 Jun; 48(2):121-9. PubMed ID: 24900152
[TBL] [Abstract][Full Text] [Related]
5. 18F-fluorodeoxyglucose positron emission tomography: useful technique for predicting malignant potential of gastrointestinal stromal tumors.
Kamiyama Y; Aihara R; Nakabayashi T; Mochiki E; Asao T; Kuwano H; Oriuchi N; Endo K
World J Surg; 2005 Nov; 29(11):1429-35. PubMed ID: 16222452
[TBL] [Abstract][Full Text] [Related]
6. [The value of (18)F-FDG PET-CT imaging in predicting the malignant potential of GIST].
Li SX; Tang MD; Lin DY; Liu DJ; Lyu QH; Zhang JP; Cai ZH
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):821-827. PubMed ID: 29151288
[No Abstract] [Full Text] [Related]
7. Clinical applications of 18F-fluorodeoxyglucose positron emission tomography in gastrointestinal stromal tumor of the esophagus.
Sakai M; Kato H; Saito K; Tanaka N; Inose T; Kimura H; Miyazaki T; Kuwano H
Int Surg; 2008; 93(4):209-13. PubMed ID: 19731855
[TBL] [Abstract][Full Text] [Related]
8. The usefulness of preoperative 18FDG positron-emission tomography and computed tomography for predicting the malignant potential of gastrointestinal stromal tumors.
Tokumoto N; Tanabe K; Misumi T; Fujikuni N; Suzuki T; Ohdan H
Dig Surg; 2014; 31(2):79-86. PubMed ID: 24776690
[TBL] [Abstract][Full Text] [Related]
9. Malignant diagnosis and prognostic analysis of 89 GIST patients using preoperative FDG-PET.
Narushima K; Shuto K; Okazumi S; Ohira G; Mori M; Hayano K; Yanagawa N; Matsubara H
Sci Rep; 2023 Feb; 13(1):2266. PubMed ID: 36755154
[TBL] [Abstract][Full Text] [Related]
10. Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer.
Higashi T; Saga T; Nakamoto Y; Ishimori T; Mamede MH; Wada M; Doi R; Hosotani R; Imamura M; Konishi J
J Nucl Med; 2002 Feb; 43(2):173-80. PubMed ID: 11850481
[TBL] [Abstract][Full Text] [Related]
11. [18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors.
Hawkins DS; Schuetze SM; Butrynski JE; Rajendran JG; Vernon CB; Conrad EU; Eary JF
J Clin Oncol; 2005 Dec; 23(34):8828-34. PubMed ID: 16314643
[TBL] [Abstract][Full Text] [Related]
12. Esophageal gastrointestinal stromal tumor: report of 7 patients.
Shinagare AB; Zukotynski KA; Krajewski KM; Jagannathan JP; Butrynski J; Hornick JL; Ramaiya NH
Cancer Imaging; 2012 Apr; 12(1):100-8. PubMed ID: 22542728
[TBL] [Abstract][Full Text] [Related]
13. Early prediction of response to sunitinib after imatinib failure by 18F-fluorodeoxyglucose positron emission tomography in patients with gastrointestinal stromal tumor.
Prior JO; Montemurro M; Orcurto MV; Michielin O; Luthi F; Benhattar J; Guillou L; Elsig V; Stupp R; Delaloye AB; Leyvraz S
J Clin Oncol; 2009 Jan; 27(3):439-45. PubMed ID: 19064982
[TBL] [Abstract][Full Text] [Related]
14. Assessment of cell proliferation in renal cell carcinoma using dual-phase
Onishi R; Noguchi M; Kaida H; Moriya F; Chikui K; Kurata S; Kawahara A; Kage M; Ishibashi M; Matsuoka K
Oncol Lett; 2015 Aug; 10(2):822-828. PubMed ID: 26622577
[TBL] [Abstract][Full Text] [Related]
15. Imaging and clinicopathologic features of esophageal gastrointestinal stromal tumors.
Winant AJ; Gollub MJ; Shia J; Antonescu C; Bains MS; Levine MS
AJR Am J Roentgenol; 2014 Aug; 203(2):306-14. PubMed ID: 25055264
[TBL] [Abstract][Full Text] [Related]
16. The value of (18) F-fluorodeoxyglucose positron emission tomography for prediction of treatment response in gastrointestinal stromal tumors: a systematic review and meta-analysis.
Hassanzadeh-Rad A; Yousefifard M; Katal S; Asady H; Fard-Esfahani A; Moghadas Jafari A; Hosseini M
J Gastroenterol Hepatol; 2016 May; 31(5):929-35. PubMed ID: 26642423
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric MRI and
Yoo J; Kim SH; Han JK
Eur Radiol; 2020 Mar; 30(3):1634-1643. PubMed ID: 31781931
[TBL] [Abstract][Full Text] [Related]
18. Correlations between dual-phase 18F-FDG uptake and clinicopathologic and biological markers of breast cancer.
Kaida H; Azuma K; Toh U; Kawahara A; Sadashima E; Hattori S; Akiba J; Tahara N; Rominger A; Ishii K; Murakami T; Ishibashi M
Hell J Nucl Med; 2018; 21(1):35-42. PubMed ID: 29550845
[TBL] [Abstract][Full Text] [Related]
19. Optimizing delayed scan time for FDG PET: comparison of the early and late delayed scan.
Chen YM; Huang G; Sun XG; Liu JJ; Chen T; Shi YP; Wan LR
Nucl Med Commun; 2008 May; 29(5):425-30. PubMed ID: 18391725
[TBL] [Abstract][Full Text] [Related]
20. The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas.
Palmerini E; Colangeli M; Nanni C; Fanti S; Marchesi E; Paioli A; Picci P; Cambioli S; Donati D; Cevolani L; De Paolis M; Gambarotti M; Ferrari S
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):215-223. PubMed ID: 27645694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]